39
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Significant frequency of allelic imbalance in 3p region covering RARβ and MLH1 loci seems to be essential in molecular non-small cell lung cancer diagnosis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of the study was to investigate the influence of allelic imbalance (AI) in several loci of tumor suppressor genes in 3p region on the non-small cell lung cancer (NSCLC) development. We evaluated the frequency of loss of heterozygosity and/or microsatellite imbalance (LOH/MSI) and assessed their association with patients’ characteristics (age, gender, tobacco addiction) and NSCLC classification according to TNM/AJCC staging. To analyze the potential role of AI involved in NSCLC pathogenesis, we allelotyped a group of 74 NSCLC patients using 7 microsatellite markers. The highest frequency of LOH/MSI, however, not statistically significant, was observed in RARβ and MLH1 ( p = 0.104 and p = 0.216, respectively) loci. The association between high LOH/MSI frequency in 3p region with male gender ( p = 0.041) as well as with age (especially >60 years) for RARβ and MLH1 genes ( p = 0.0001 and p = 0.020, respectively) was documented. Statistically significant increased frequency of MLH1 allelic loss in squamous cell carcinoma (SCC) versus non-squamous cell carcinoma (non-SCC) was observed ( p = 0.01). Significant increase in LOH/MSI frequency in 3p region (mainly in FHIT and MLH1 loci) in correlation with cigarette addiction in a lifetime (≥40 years and ≥40 Pack Years) was also documented ( p < 0.05). The highest LOH/MSI was revealed in RARβ locus in IA tumors ( p = 0.0001), while the similarly high allelic loss of MLH1 correlated with III A/B tumors ( p = 0.0002), according to AJCC staging. The obtained results demonstrate that AI is influenced by tobacco smoking and seems to be vital in the molecular diagnosis of NSCLC, especially of SCC subtype.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Characterizing the cancer genome in lung adenocarcinoma.

          Somatic alterations in cellular DNA underlie almost all human cancers. The prospect of targeted therapies and the development of high-resolution, genome-wide approaches are now spurring systematic efforts to characterize cancer genomes. Here we report a large-scale project to characterize copy-number alterations in primary lung adenocarcinomas. By analysis of a large collection of tumours (n = 371) using dense single nucleotide polymorphism arrays, we identify a total of 57 significantly recurrent events. We find that 26 of 39 autosomal chromosome arms show consistent large-scale copy-number gain or loss, of which only a handful have been linked to a specific gene. We also identify 31 recurrent focal events, including 24 amplifications and 7 homozygous deletions. Only six of these focal events are currently associated with known mutations in lung carcinomas. The most common event, amplification of chromosome 14q13.3, is found in approximately 12% of samples. On the basis of genomic and functional analyses, we identify NKX2-1 (NK2 homeobox 1, also called TITF1), which lies in the minimal 14q13.3 amplification interval and encodes a lineage-specific transcription factor, as a novel candidate proto-oncogene involved in a significant fraction of lung adenocarcinomas. More generally, our results indicate that many of the genes that are involved in lung adenocarcinoma remain to be discovered.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Diversity of gene expression in adenocarcinoma of the lung.

            The global gene expression profiles for 67 human lung tumors representing 56 patients were examined by using 24,000-element cDNA microarrays. Subdivision of the tumors based on gene expression patterns faithfully recapitulated morphological classification of the tumors into squamous, large cell, small cell, and adenocarcinoma. The gene expression patterns made possible the subclassification of adenocarcinoma into subgroups that correlated with the degree of tumor differentiation as well as patient survival. Gene expression analysis thus promises to extend and refine standard pathologic analysis.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Cancer statistics, 2000

                Bookmark

                Author and article information

                Contributors
                +48-42-6757715 , ewa.brzezianska@umed.lodz.pl
                Journal
                Med Oncol
                Med. Oncol
                Medical Oncology (Northwood, London, England)
                Springer US (Boston )
                1357-0560
                1559-131X
                17 March 2013
                17 March 2013
                June 2013
                : 30
                : 2
                : 532
                Affiliations
                [ ]Department of General and Oncological Pulmonology, Medical University of Lodz, Kopcińskiego St.22, 90-153 Lodz, Poland
                [ ]1st Chair of Internal Diseases, Department of Molecular Bases of Medicine, Medical University of Lodz, Pomorska St. 251, 92-213 Lodz, Poland
                [ ]Department of Thoracic Surgery, General and Oncologic Surgery, Medical University of Lodz, Żeromskiego St. 113, 90-710 Lodz, Poland
                [ ]Department of Pneumology and Allergology, Medical University of Lodz, Kopcińskiego St. 22, 90-153 Lodz, Poland
                Article
                532
                10.1007/s12032-013-0532-9
                3667378
                23504373
                6179eb82-6dcb-4ee0-9e17-41e47b141a56
                © The Author(s) 2013

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

                History
                : 15 January 2013
                : 2 March 2013
                Categories
                Original Paper
                Custom metadata
                © Springer Science+Business Media New York 2013

                Oncology & Radiotherapy
                non-small cell lung carcinoma (nsclc),loss of heterozygosity (loh),microsatellite instability (msi),microsatellite markers,molecular diagnosis

                Comments

                Comment on this article